Frank Sullivan, FRCP, FRCGP, PhD
Sullivan F. Pegaptanib was effective and safe without a dose-response relation in neovascular, age-related, macular degeneration. ACP J Club. 2005;143:18. doi: 10.7326/ACPJC-2005-143-1-018
Download citation file:
Published: ACP J Club 2005;143(1):18.
Learn more about subscription options.
Register Now for a free account.
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only